 | • レポートコード：D0804-06136 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ダビガトランの世界市場を広く調査・分析し、今後の市場展望をまとめております。ダビガトランの種類別市場規模（プラダクサ、プラダックス、プラザクサ）、用途別市場規模（脳卒中、深部静脈血栓症、肺塞栓症、全身性塞栓症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer, Inc. (US)、Bristol-Myers Squibb Company (US)、Boehringer Ingelheim (Germany)、Bayer Healthcare AG (Germany)、Aspen Holdings (South Africa)、GlaxoSmithKline Plc. (UK)、Mitsubishi Tanabe Pharma Corporation (Japan)、Abbott India Limited (India)、Sanofi S.A. (France)、Eisai Inc. (US)、Teva Pharmaceutical Industries Ltd. (Israel) ・地域別グローバル市場分析 2015年-2020年 ・ダビガトランの北米市場（アメリカ、カナダ、メキシコ） ・ダビガトランのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ダビガトランのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ダビガトランの南米市場（ブラジル、アルゼンチン） ・ダビガトランの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プラダクサ、プラダックス、プラザクサ ・用途別分析：脳卒中、深部静脈血栓症、肺塞栓症、全身性塞栓症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dibigatran market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Dibigatran market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dibigatran market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dibigatran market has been segmented into
Pradaxa
Pradax
Prazaxa
By Application, Dibigatran has been segmented into:
stroke
deep vein thrombosis
pulmonary embolism
systemic embolism
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dibigatran market presented in the report. This section sheds light on the sales growth of different regional and country-level Dibigatran markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dibigatran market.
The report offers in-depth assessment of the growth and other aspects of the Dibigatran market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dibigatran Market Share Analysis
Dibigatran competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dibigatran sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dibigatran sales, revenue and market share for each player covered in this report.
The major players covered in Dibigatran are:
Pfizer, Inc. (US)
Bristol-Myers Squibb Company (US)
Boehringer Ingelheim (Germany)
Bayer Healthcare AG (Germany)
Aspen Holdings (South Africa)
GlaxoSmithKline Plc. (UK)
Mitsubishi Tanabe Pharma Corporation (Japan)
Abbott India Limited (India)
Sanofi S.A. (France)
Eisai Inc. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Among other players domestic and global, Dibigatran market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dibigatran product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dibigatran, with price, sales, revenue and global market share of Dibigatran in 2018 and 2019.
Chapter 3, the Dibigatran competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dibigatran breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dibigatran market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dibigatran sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dibigatran Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dibigatran Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pradaxa
1.2.3 Pradax
1.2.4 Prazaxa
1.3 Market Analysis by Application
1.3.1 Overview: Global Dibigatran Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 stroke
1.3.3 deep vein thrombosis
1.3.4 pulmonary embolism
1.3.5 systemic embolism
1.4 Overview of Global Dibigatran Market
1.4.1 Global Dibigatran Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc. (US)
2.1.1 Pfizer, Inc. (US) Details
2.1.2 Pfizer, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer, Inc. (US) SWOT Analysis
2.1.4 Pfizer, Inc. (US) Product and Services
2.1.5 Pfizer, Inc. (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb Company (US)
2.2.1 Bristol-Myers Squibb Company (US) Details
2.2.2 Bristol-Myers Squibb Company (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb Company (US) SWOT Analysis
2.2.4 Bristol-Myers Squibb Company (US) Product and Services
2.2.5 Bristol-Myers Squibb Company (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim (Germany)
2.3.1 Boehringer Ingelheim (Germany) Details
2.3.2 Boehringer Ingelheim (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim (Germany) SWOT Analysis
2.3.4 Boehringer Ingelheim (Germany) Product and Services
2.3.5 Boehringer Ingelheim (Germany) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Healthcare AG (Germany)
2.4.1 Bayer Healthcare AG (Germany) Details
2.4.2 Bayer Healthcare AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Healthcare AG (Germany) SWOT Analysis
2.4.4 Bayer Healthcare AG (Germany) Product and Services
2.4.5 Bayer Healthcare AG (Germany) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aspen Holdings (South Africa)
2.5.1 Aspen Holdings (South Africa) Details
2.5.2 Aspen Holdings (South Africa) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aspen Holdings (South Africa) SWOT Analysis
2.5.4 Aspen Holdings (South Africa) Product and Services
2.5.5 Aspen Holdings (South Africa) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline Plc. (UK)
2.6.1 GlaxoSmithKline Plc. (UK) Details
2.6.2 GlaxoSmithKline Plc. (UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline Plc. (UK) SWOT Analysis
2.6.4 GlaxoSmithKline Plc. (UK) Product and Services
2.6.5 GlaxoSmithKline Plc. (UK) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mitsubishi Tanabe Pharma Corporation (Japan)
2.7.1 Mitsubishi Tanabe Pharma Corporation (Japan) Details
2.7.2 Mitsubishi Tanabe Pharma Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mitsubishi Tanabe Pharma Corporation (Japan) SWOT Analysis
2.7.4 Mitsubishi Tanabe Pharma Corporation (Japan) Product and Services
2.7.5 Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott India Limited (India)
2.8.1 Abbott India Limited (India) Details
2.8.2 Abbott India Limited (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott India Limited (India) SWOT Analysis
2.8.4 Abbott India Limited (India) Product and Services
2.8.5 Abbott India Limited (India) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi S.A. (France)
2.9.1 Sanofi S.A. (France) Details
2.9.2 Sanofi S.A. (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi S.A. (France) SWOT Analysis
2.9.4 Sanofi S.A. (France) Product and Services
2.9.5 Sanofi S.A. (France) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eisai Inc. (US)
2.10.1 Eisai Inc. (US) Details
2.10.2 Eisai Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eisai Inc. (US) SWOT Analysis
2.10.4 Eisai Inc. (US) Product and Services
2.10.5 Eisai Inc. (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical Industries Ltd. (Israel)
2.11.1 Teva Pharmaceutical Industries Ltd. (Israel) Details
2.11.2 Teva Pharmaceutical Industries Ltd. (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
2.11.4 Teva Pharmaceutical Industries Ltd. (Israel) Product and Services
2.11.5 Teva Pharmaceutical Industries Ltd. (Israel) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dibigatran Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dibigatran Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dibigatran Manufacturer Market Share in 2019
3.3.2 Top 6 Dibigatran Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dibigatran Sales, Revenue and Market Share by Regions
4.1.1 Global Dibigatran Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dibigatran Revenue and Market Share by Regions (2015-2020)
4.2 North America Dibigatran Sales and Growth Rate (2015-2020)
4.3 Europe Dibigatran Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dibigatran Sales and Growth Rate (2015-2020)
4.5 South America Dibigatran Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dibigatran Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dibigatran Sales, Revenue and Market Share by Country
5.1.1 North America Dibigatran Sales and Market Share by Country (2015-2020)
5.1.2 North America Dibigatran Revenue and Market Share by Country (2015-2020)
5.2 United States Dibigatran Sales and Growth Rate (2015-2020)
5.3 Canada Dibigatran Sales and Growth Rate (2015-2020)
5.4 Mexico Dibigatran Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dibigatran Sales, Revenue and Market Share by Country
6.1.1 Europe Dibigatran Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dibigatran Revenue and Market Share by Country (2015-2020)
6.2 Germany Dibigatran Sales and Growth Rate (2015-2020)
6.3 UK Dibigatran Sales and Growth Rate (2015-2020)
6.4 France Dibigatran Sales and Growth Rate (2015-2020)
6.5 Russia Dibigatran Sales and Growth Rate (2015-2020)
6.6 Italy Dibigatran Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dibigatran Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dibigatran Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dibigatran Revenue and Market Share by Regions (2015-2020)
7.2 China Dibigatran Sales and Growth Rate (2015-2020)
7.3 Japan Dibigatran Sales and Growth Rate (2015-2020)
7.4 Korea Dibigatran Sales and Growth Rate (2015-2020)
7.5 India Dibigatran Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dibigatran Sales and Growth Rate (2015-2020)
7.7 Australia Dibigatran Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dibigatran Sales, Revenue and Market Share by Country
8.1.1 South America Dibigatran Sales and Market Share by Country (2015-2020)
8.1.2 South America Dibigatran Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dibigatran Sales and Growth Rate (2015-2020)
8.3 Argentina Dibigatran Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dibigatran Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dibigatran Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dibigatran Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dibigatran Sales and Growth Rate (2015-2020)
9.3 Turkey Dibigatran Sales and Growth Rate (2015-2020)
9.4 Egypt Dibigatran Sales and Growth Rate (2015-2020)
9.5 South Africa Dibigatran Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dibigatran Sales and Market Share by Type (2015-2020)
10.2 Global Dibigatran Revenue and Market Share by Type (2015-2020)
10.3 Global Dibigatran Price by Type (2015-2020)
11 Global Dibigatran Market Segment by Application
11.1 Global Dibigatran Sales Market Share by Application (2015-2020)
11.2 Global Dibigatran Revenue Market Share by Application (2015-2020)
11.3 Global Dibigatran Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dibigatran Sales, Revenue and Growth Rate (2021-2025)
12.2 Dibigatran Market Forecast by Regions (2021-2025)
12.2.1 North America Dibigatran Market Forecast (2021-2025)
12.2.2 Europe Dibigatran Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dibigatran Market Forecast (2021-2025)
12.2.4 South America Dibigatran Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dibigatran Market Forecast (2021-2025)
12.3 Dibigatran Market Forecast by Type (2021-2025)
12.3.1 Global Dibigatran Sales Forecast by Type (2021-2025)
12.3.2 Global Dibigatran Market Share Forecast by Type (2021-2025)
12.4 Dibigatran Market Forecast by Application (2021-2025)
12.4.1 Global Dibigatran Sales Forecast by Application (2021-2025)
12.4.2 Global Dibigatran Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dibigatran Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dibigatran by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dibigatran Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc. (US) Dibigatran Major Business
Table 9. Pfizer, Inc. (US) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer, Inc. (US) SWOT Analysis
Table 11. Pfizer, Inc. (US) Dibigatran Product and Services
Table 12. Pfizer, Inc. (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Company (US) Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Company (US) Dibigatran Major Business
Table 15. Bristol-Myers Squibb Company (US) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb Company (US) SWOT Analysis
Table 17. Bristol-Myers Squibb Company (US) Dibigatran Product and Services
Table 18. Bristol-Myers Squibb Company (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim (Germany) Dibigatran Major Business
Table 21. Boehringer Ingelheim (Germany) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 22. Boehringer Ingelheim (Germany) SWOT Analysis
Table 23. Boehringer Ingelheim (Germany) Dibigatran Product and Services
Table 24. Boehringer Ingelheim (Germany) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Healthcare AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Healthcare AG (Germany) Dibigatran Major Business
Table 27. Bayer Healthcare AG (Germany) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 28. Bayer Healthcare AG (Germany) SWOT Analysis
Table 29. Bayer Healthcare AG (Germany) Dibigatran Product and Services
Table 30. Bayer Healthcare AG (Germany) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Aspen Holdings (South Africa) Basic Information, Manufacturing Base and Competitors
Table 32. Aspen Holdings (South Africa) Dibigatran Major Business
Table 33. Aspen Holdings (South Africa) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 34. Aspen Holdings (South Africa) SWOT Analysis
Table 35. Aspen Holdings (South Africa) Dibigatran Product and Services
Table 36. Aspen Holdings (South Africa) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Plc. (UK) Dibigatran Major Business
Table 39. GlaxoSmithKline Plc. (UK) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline Plc. (UK) SWOT Analysis
Table 41. GlaxoSmithKline Plc. (UK) Dibigatran Product and Services
Table 42. GlaxoSmithKline Plc. (UK) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information, Manufacturing Base and Competitors
Table 44. Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Major Business
Table 45. Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 46. Mitsubishi Tanabe Pharma Corporation (Japan) SWOT Analysis
Table 47. Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Product and Services
Table 48. Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Abbott India Limited (India) Basic Information, Manufacturing Base and Competitors
Table 50. Abbott India Limited (India) Dibigatran Major Business
Table 51. Abbott India Limited (India) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 52. Abbott India Limited (India) SWOT Analysis
Table 53. Abbott India Limited (India) Dibigatran Product and Services
Table 54. Abbott India Limited (India) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi S.A. (France) Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi S.A. (France) Dibigatran Major Business
Table 57. Sanofi S.A. (France) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 58. Sanofi S.A. (France) SWOT Analysis
Table 59. Sanofi S.A. (France) Dibigatran Product and Services
Table 60. Sanofi S.A. (France) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eisai Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 62. Eisai Inc. (US) Dibigatran Major Business
Table 63. Eisai Inc. (US) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 64. Eisai Inc. (US) SWOT Analysis
Table 65. Eisai Inc. (US) Dibigatran Product and Services
Table 66. Eisai Inc. (US) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Industries Ltd. (Israel) Dibigatran Major Business
Table 69. Teva Pharmaceutical Industries Ltd. (Israel) Dibigatran Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
Table 71. Teva Pharmaceutical Industries Ltd. (Israel) Dibigatran Product and Services
Table 72. Teva Pharmaceutical Industries Ltd. (Israel) Dibigatran Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Dibigatran Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Dibigatran Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Dibigatran Sales by Regions (2015-2020) (K Units)
Table 76. Global Dibigatran Sales Market Share by Regions (2015-2020)
Table 77. Global Dibigatran Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Dibigatran Sales by Countries (2015-2020) (K Units)
Table 79. North America Dibigatran Sales Market Share by Countries (2015-2020)
Table 80. North America Dibigatran Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Dibigatran Revenue Market Share by Countries (2015-2020)
Table 82. Europe Dibigatran Sales by Countries (2015-2020) (K Units)
Table 83. Europe Dibigatran Sales Market Share by Countries (2015-2020)
Table 84. Europe Dibigatran Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Dibigatran Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Dibigatran Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Dibigatran Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Dibigatran Sales by Countries (2015-2020) (K Units)
Table 89. South America Dibigatran Sales Market Share by Countries (2015-2020)
Table 90. South America Dibigatran Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Dibigatran Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Dibigatran Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Dibigatran Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Dibigatran Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Dibigatran Revenue Market Share by Countries (2015-2020)
Table 96. Global Dibigatran Sales by Type (2015-2020) (K Units)
Table 97. Global Dibigatran Sales Share by Type (2015-2020)
Table 98. Global Dibigatran Revenue by Type (2015-2020) (USD Million)
Table 99. Global Dibigatran Revenue Share by Type (2015-2020)
Table 100. Global Dibigatran Sales by Application (2015-2020) (K Units)
Table 101. Global Dibigatran Sales Share by Application (2015-2020)
Table 102. Global Dibigatran Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Dibigatran Market Share Forecast by Regions (2021-2025)
Table 104. Global Dibigatran Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Dibigatran Market Share Forecast by Type (2021-2025)
Table 106. Global Dibigatran Sales Forecast by Application (2021-2025)
Table 107. Global Dibigatran Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dibigatran Picture
Figure 2. Global Sales Market Share of Dibigatran by Type in 2019
Figure 3. Pradaxa Picture
Figure 4. Pradax Picture
Figure 5. Prazaxa Picture
Figure 6. Dibigatran Sales Market Share by Application in 2018
Figure 7. stroke Picture
Figure 8. deep vein thrombosis Picture
Figure 9. pulmonary embolism Picture
Figure 10. systemic embolism Picture
Figure 11. Global Dibigatran Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Dibigatran Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Dibigatran Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Dibigatran Sales Market Share by Manufacturer in 2019
Figure 32. Global Dibigatran Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Dibigatran Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Dibigatran Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Dibigatran Revenue Market Share by Regions (2015-2020)
Figure 39. Global Dibigatran Revenue Market Share by Regions in 2018
Figure 40. North America Dibigatran Sales and Growth Rate (2015-2020)
Figure 41. Europe Dibigatran Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Dibigatran Sales and Growth Rate (2015-2020)
Figure 43. South America Dibigatran Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Dibigatran Sales and Growth Rate (2015-2020)
Figure 45. North America Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Dibigatran Sales Market Share by Countries (2015-2020)
Figure 47. North America Dibigatran Sales Market Share by Countries in 2018
Figure 48. North America Dibigatran Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Dibigatran Revenue Market Share by Countries in 2018
Figure 50. United States Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Dibigatran Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Dibigatran Revenue Market Share by Countries in 2019
Figure 56. Germany Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Dibigatran Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Dibigatran Revenue Market Share by Regions 2019
Figure 64. China Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Dibigatran Sales Market Share by Countries in 2019
Figure 71. South America Dibigatran Revenue Market Share by Countries in 2019
Figure 72. Brazil Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Dibigatran Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Dibigatran Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Dibigatran Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Dibigatran Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Dibigatran Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Dibigatran Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Dibigatran Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Dibigatran Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Dibigatran Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Dibigatran Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Dibigatran Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Dibigatran Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
肺塞栓症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Pulmonary Embolism Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 深部静脈血栓症ポンプの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Deep Vein Thrombosis Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 深部静脈血栓症（DVT）ポンプの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Deep Vein Thrombosis (DVT) Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 塞栓症予防ストッキングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Embolism Stockings market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Embolism Stockin…
- 圧迫着衣療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Compression Clothing Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Compression Clot…